The invention relates to an auto injector with a hydraulic actuator and a separate drug distribution system for subcutaneous injection of a therapeutic drug, wherein the drug distribution system provides a fluid pathway between a drug filled container and a hypodermic needle only when the auto injector is activated.
A61M 5/20 - Seringues automatiques, p. ex. avec tige de piston actionnée automatiquement, avec injection automatique de l'aiguille, à remplissage automatique
A61M 5/24 - Seringues à ampoules, c.-à-d. seringues à aiguille utilisables avec des ampoules ou des cartouches échangeables, p. ex. automatiques
A61M 5/315 - PistonsTiges de pistonGuidage, blocage, ou limitation des mouvements de la tigeAccessoires disposés sur la tige pour faciliter le dosage
A61M 5/32 - AiguillesParties constitutives des aiguilles relatives au raccordement de celles-ci à la seringue ou au manchonAccessoires pour introduire l'aiguille dans le corps ou l'y maintenirDispositifs pour la protection des aiguilles
A61M 5/34 - Structures pour le raccordement de l'aiguille
2.
OSMOTIC ACTUATOR FOR A WEARABLE INJECTION DEVICE AND A WEARABLE INJECTION DEVICE COMPRISING SUCH AN OSMOTIC ACTUATOR
An osmotic actuator (110) for a wearable injection device (100) is disclosed, which osmotic actuator comprises a pressure chamber (150) having one or more outlets (152) and containing a draw solution containing dissolved inorganic salt, one or more osmotic membranes (130), and a cavity (140) containing water, and wherein the one or more osmotic membranes (130) form at least a part of one or more internal surfaces of the pressure chamber (150), wherein the water is in contact with at least a part of one or more external surfaces of the one or more osmotic membranes (130), and wherein the dissolved inorganic salt in the draw solution comprises one or more of the following: CaBr2, CaCl2, ZnBr2, ZnCl2, ZnI2 or LiBr. Furthermore, a wearable injection device (100) comprising such an osmotic actuator (110) and the use of such inorganic salts in a draw solution are disclosed.
222222 or LiBr. Furthermore, a wearable injection device (100) comprising such an osmotic actuator (110) and the use of such inorganic salts in a draw solution are disclosed.
An osmotic actuator (110) for an injection device (100) is disclosed, which osmotic actuator (110) comprises a pressure chamber (180; 280; 380) having one or more outlets (182; 282; 295; 395) and containing a draw solution, one or more osmotic membranes (130), a cavity (140) containing water, and a dilution-compensating arrangement, wherein the one or more osmotic membranes (130) forms a part of an internal surface area of the pressure chamber (180; 280; 380), wherein the cavity (140) containing water abuts at least part of an external surface of the one or more osmotic membranes (130), and wherein the dilution-compensating arrangement is arranged to compensate for the dilution of the draw solution near the one or more osmotic membranes (130), which occurs when water from the cavity (140) enters the pressure chamber (180; 280; 380) through the one or more osmotic membranes (130). Furthermore, an injection device (100) comprising such an osmotic actuator (110) is disclosed.
A valve (116, 216) for an injection device (100) is disclosed, which valve is arranged to provide a fluid communication between a drug-filled container (102, 202) and a drug distribution system (101) for distributing a drug to an injection site during use of the device, wherein the valve is substantially cylindrically shaped and is arranged to be at least partly positioned within an outlet portion (123, 223) of the container so that, in an initial configuration, the valve tightly closes the outlet portion, wherein the valve is arranged to be moved through a first distance in a first direction partly into the con- tainer, whereby fluid communication is established through the outlet portion of the container, and wherein the valve is further arranged to be moved through a second distance in a second direction opposite of the first direction.Furthermore, an injection device (100) comprising such a valve (116, 126) is disclosed.
The invention relates to a wearable injection device (1) for subcutaneous injection of a therapeutic agent, wherein the dose is injected over a specified period of time after the device is activated.